Author:
Guembitskaia Tatiana E.,Vishnyakova Ludmila A.,Zhelenina Ludmila A.,Kapranov Nikolai J.
Reference15 articles.
1. Baranov VS, Ivaschcnko TE, Gorbunova VN, Livshitz LA, Venozinskis MT, Gemhovskaya SA et al. Frequency of the F508 deletion in cystic fibrosis patients from the European part of the USSR. Hum Genet 1991; 87: 61–64.
2. Bogdanova AV, Gelenina LA, Blinova T, Mustafaev I, Kovaleva L, Perley V. La mucoviscidose au Centre de Saint-Pétersbourg. Etude clinique, génétique et thérapeutique. Pédiatre 1991: 27: 103–106.
3. Döring G, Maier M. Müller E, Bibi Z, Tümmler B, Kharazmi A. Virulence factors of Psewlomonas aeruginosa. Antibiot Chemother 1987; 39: 136–148.
4. During G. Chronic Preudomonas aeruginosa lung infection in cystic fibrosis. In: M. Campa, M. Bandinelli, H. Friedman (eds.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York 1993, pp. 245–273.
5. Feigelson J, Pecau Y, Gaultier L, Boule M. Cures intensives d’antibiotiques dans les mucoviscidoses évoluées. Nouv Presse Méd 1981; 10: 955–958.